Onglyza Lawsuits Exceed 200 as Claims of Cardiovascular Injury Grow
On June 15th, the Judicial Panel on Multidistrict Litigation (JPML) issued a report on pending MDL dockets currently active in all U.S. District Courts. The…
Health
The Complications of Severe Hypophosphatemia and the Drug that Causes it: Injectafer
In recent years, intravenous iron medication has skyrocketed in popularity in the United States as a means of treatment for those 4.5 million Americans who…
Hernia Mesh Problems Continue into 2018
It was not far into the New Year when Ethicon, Inc.—a Johnson & Johnson subsidiary—was named in a hernia mesh lawsuit filed in Idaho by…
Nuedexta: Did Greed Push this Pill’s Popularity?
Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience…
New Study Says Heart Stents Are Ineffective for Pain
According to the Centers for Disease Control and Prevention (CDC), about 735,000 people suffer a heart attack each year in the U.S.—making heart disease the…
Could New FDA Commissioner Lift Drug Label Restrictions?
While the Food and Drug Administration (FDA) is charged with supervising a wide array of public health concerns that include blood transfusions, radiation-emitting devices, tobacco…
Risperdal Trials Set for Next Month as Number of New Cases Continues to Grow
Mass tort cases continue to pile up for Johnson & Johnson (J&J) and their subsidiaries. So is the case with Risperdal, a treatment for bipolar…
Invokana Called into Question with Latest FDA Warning
When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as…
Hernia Mesh Cases Move Forward with MDL
In December, I wrote a blog discussing the likelihood of MultiDistrict Litigation (MDL) for two manufacturers of a hernia mesh surgical device—Atrium Medical who produces…
Hyland’s Products Could Still Harm Your Baby
On October 11, 2016, homeopathic medicine manufacturer Hyland’s issued a public letter to parents everywhere. Beginning with “Dear Moms and Dads…” the corporate communication went…